BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 30624092)

  • 1. The effect of leukocyte-platelet-rich fibrin on bone morphogenetic protein-2 and insulin-like growth factor-1 levels in patients with chronic periodontitis: a randomized split mouth clinical trail.
    Kizildağ A; Çiçek Y; Arabaci T; Köse O
    Growth Factors; 2018 Dec; 36(5-6):239-245. PubMed ID: 30624092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advantages of Autologous Platelet-Rich Fibrin Membrane on Gingival Crevicular Fluid Growth Factor Levels and Periodontal Healing: A Randomized Split-Mouth Clinical Study.
    Arabacı T; Kose O; Albayrak M; Cicek Y; Kizildag A
    J Periodontol; 2017 Aug; 88(8):771-777. PubMed ID: 28452623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet-rich fibrin with 1% metformin for the treatment of intrabony defects in chronic periodontitis: a randomized controlled clinical trial.
    Pradeep AR; Nagpal K; Karvekar S; Patnaik K; Naik SB; Guruprasad CN
    J Periodontol; 2015 Jun; 86(6):729-37. PubMed ID: 25762357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-Rich Fibrin Combined With a Porous Hydroxyapatite Graft for the Treatment of 3-Wall Intrabony Defects in Chronic Periodontitis: A Randomized Controlled Clinical Trial.
    Pradeep AR; Bajaj P; Rao NS; Agarwal E; Naik SB
    J Periodontol; 2017 Dec; 88(12):1288-1296. PubMed ID: 29314065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Titanium-prepared platelet-rich fibrin provides advantages on periodontal healing: A randomized split-mouth clinical study.
    Arabaci T; Albayrak M
    J Periodontol; 2018 Mar; 89(3):255-264. PubMed ID: 29543995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and radiographic evaluation of low-speed platelet-rich fibrin (PRF) for the treatment of intra-osseous defects of stage-III periodontitis patients: a randomized controlled clinical trial.
    Abdulrahman YA; Hosny MM; Elfana A; Fawzy El-Sayed KM
    Clin Oral Investig; 2022 Nov; 26(11):6671-6680. PubMed ID: 35876893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative evaluation of autologous platelet-rich fibrin and platelet-rich plasma in the treatment of mandibular degree II furcation defects: a randomized controlled clinical trial.
    Bajaj P; Pradeep AR; Agarwal E; Rao NS; Naik SB; Priyanka N; Kalra N
    J Periodontal Res; 2013 Oct; 48(5):573-81. PubMed ID: 23317096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous platelet-rich fibrin stimulates canine periodontal regeneration.
    Kornsuthisopon C; Pirarat N; Osathanon T; Kalpravidh C
    Sci Rep; 2020 Feb; 10(1):1850. PubMed ID: 32024893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and radiographic effects of ascorbic acid-augmented platelet-rich fibrin versus platelet-rich fibrin alone in intra-osseous defects of stage-III periodontitis patients: a randomized controlled clinical trial.
    Elbehwashy MT; Hosny MM; Elfana A; Nawar A; Fawzy El-Sayed K
    Clin Oral Investig; 2021 Nov; 25(11):6309-6319. PubMed ID: 33842996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-Rich Fibrin Combined With 1.2% Atorvastatin for Treatment of Intrabony Defects in Chronic Periodontitis: A Randomized Controlled Clinical Trial.
    Martande SS; Kumari M; Pradeep AR; Singh SP; Suke DK; Guruprasad CN
    J Periodontol; 2016 Sep; 87(9):1039-46. PubMed ID: 27294433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-Rich Fibrin With 1.2% Rosuvastatin for Treatment of Intrabony Defects in Chronic Periodontitis: A Randomized Controlled Clinical Trial.
    Pradeep AR; Garg V; Kanoriya D; Singhal S
    J Periodontol; 2016 Dec; 87(12):1468-1473. PubMed ID: 27452270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous Platelet-Rich Fibrin in the Treatment of 3-Wall Intrabony Defects in Aggressive Periodontitis: A Randomized Controlled Clinical Trial.
    Bajaj P; Agarwal E; Rao NS; Naik SB; Pradeep AR; Kalra N; Priyanka N; Kumari M
    J Periodontol; 2017 Nov; 88(11):1186-1191. PubMed ID: 28820320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gingival crevicular fluid vascular endothelial cell growth factor and platelet-derived growth factor-BB release profile following the use of perforated barrier membranes during treatment of intrabony defects: a randomized clinical trial.
    Gamal AY; Abdel-Ghaffar KA; Iacono VJ
    J Periodontal Res; 2016 Jun; 51(3):407-16. PubMed ID: 26549803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of platelet-rich fibrin for the treatment of periodontal intrabony defects: a systematic review and meta-analysis.
    Miron RJ; Moraschini V; Fujioka-Kobayashi M; Zhang Y; Kawase T; Cosgarea R; Jepsen S; Bishara M; Canullo L; Shirakata Y; Gruber R; Ferenc D; Calasans-Maia MD; Wang HL; Sculean A
    Clin Oral Investig; 2021 May; 25(5):2461-2478. PubMed ID: 33609186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative evaluation of autologous platelet-rich fibrin and platelet-rich plasma in the treatment of 3-wall intrabony defects in chronic periodontitis: a randomized controlled clinical trial.
    Pradeep AR; Rao NS; Agarwal E; Bajaj P; Kumari M; Naik SB
    J Periodontol; 2012 Dec; 83(12):1499-507. PubMed ID: 22348695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-Rich Fibrin in Regeneration of Intrabony Defects: A Randomized Controlled Trial.
    Patel GK; Gaekwad SS; Gujjari SK; S C VK
    J Periodontol; 2017 Nov; 88(11):1192-1199. PubMed ID: 28820322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjunctive effect of collagen membrane coverage to L-PRF in the treatment of periodontal intrabony defects: a randomized controlled clinical trial with biochemical assessment.
    Mubarak R; Adel-Khattab D; Abdel-Ghaffar KA; Gamal AY
    BMC Oral Health; 2023 Sep; 23(1):631. PubMed ID: 37667213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical treatment of periodontal intrabony defects with calcium sulfate implant and barrier versus collagen barrier or open flap debridement alone: a 12-month randomized controlled clinical trial.
    Paolantonio M; Perinetti G; Dolci M; Perfetti G; Tetè S; Sammartino G; Femminella B; Graziani F
    J Periodontol; 2008 Oct; 79(10):1886-93. PubMed ID: 18834243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Vascular Endothelial Growth Factor Using Platelet Rich Fibrin (PRF) and Nanohydroxyapatite (nano-HA) in Treatment of Periodontal Intra-Bony Defects - A Randomized Controlled Trial.
    Bahammam MA; Attia MS
    Saudi J Biol Sci; 2021 Jan; 28(1):870-878. PubMed ID: 33424378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of periodontal intrabony defects using autologous platelet-rich fibrin and titanium platelet-rich fibrin: a randomized, clinical, comparative study.
    Chatterjee A; Pradeep AR; Garg V; Yajamanya S; Ali MM; Priya VS
    J Investig Clin Dent; 2017 Aug; 8(3):. PubMed ID: 27477110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.